Overview

The Use of Metformin in Early Breast Cancer Patients Pre-Surgery

Status:
Withdrawn
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
The study will test metformin in patients with early breast cancer. Blood and tissue will be collected before and after the use of metformin.
Phase:
Early Phase 1
Details
Lead Sponsor:
Instituto Nacional de Cancer, Brazil
Treatments:
Metformin